SU591147A3 - Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей - Google Patents

Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей

Info

Publication number
SU591147A3
SU591147A3 SU752162235A SU2162235A SU591147A3 SU 591147 A3 SU591147 A3 SU 591147A3 SU 752162235 A SU752162235 A SU 752162235A SU 2162235 A SU2162235 A SU 2162235A SU 591147 A3 SU591147 A3 SU 591147A3
Authority
SU
USSR - Soviet Union
Prior art keywords
tetrahydrofurfuryl
dimethyl
mol
hydroxy
methanol
Prior art date
Application number
SU752162235A
Other languages
English (en)
Russian (ru)
Inventor
Мерц Герберт
Лангбейн Адольф
Вальтер Герхард
Штокхаус Клаус
Original Assignee
К.Х Берингер Зон (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by К.Х Берингер Зон (Фирма) filed Critical К.Х Берингер Зон (Фирма)
Application granted granted Critical
Publication of SU591147A3 publication Critical patent/SU591147A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU752162235A 1974-08-05 1975-07-25 Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей SU591147A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437610A DE2437610A1 (de) 1974-08-05 1974-08-05 Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
SU591147A3 true SU591147A3 (ru) 1978-01-30

Family

ID=5922448

Family Applications (3)

Application Number Title Priority Date Filing Date
SU752162235A SU591147A3 (ru) 1974-08-05 1975-07-25 Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей
SU762346107A SU587858A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9- -дизамещенных-2-тетрагидрофурфурил-6,7бензоморфанов или их солей
SU762346108A SU587859A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9 -дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей

Family Applications After (2)

Application Number Title Priority Date Filing Date
SU762346107A SU587858A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9- -дизамещенных-2-тетрагидрофурфурил-6,7бензоморфанов или их солей
SU762346108A SU587859A3 (ru) 1974-08-05 1976-04-16 Способ получени 5,9 -дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей

Country Status (27)

Country Link
US (1) US3982005A (https=)
JP (1) JPS60358B2 (https=)
AT (1) AT348140B (https=)
BE (1) BE832099R (https=)
BG (3) BG25089A3 (https=)
CA (1) CA1049008A (https=)
CH (7) CH613963A5 (https=)
CS (1) CS189717B2 (https=)
DD (1) DD122685A5 (https=)
DE (1) DE2437610A1 (https=)
DK (1) DK138992C (https=)
ES (6) ES452763A1 (https=)
FI (1) FI63229C (https=)
FR (1) FR2320096A2 (https=)
GB (1) GB1513950A (https=)
HU (1) HU177952B (https=)
IE (1) IE42216B1 (https=)
IL (1) IL47860A (https=)
LU (1) LU73138A1 (https=)
NL (1) NL7509249A (https=)
NO (1) NO143460C (https=)
PH (1) PH13687A (https=)
PL (3) PL99838B1 (https=)
RO (3) RO67390A (https=)
SE (1) SE425392B (https=)
SU (3) SU591147A3 (https=)
ZA (1) ZA754997B (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087532A (en) * 1974-03-09 1978-05-02 Boehringer Ingelheim Gmbh Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
GB1575009A (en) * 1976-06-21 1980-09-17 Acf Chemiefarma Nv 6,7-benzomorphan derivatives
DE2716687A1 (de) * 1977-04-15 1978-10-19 Boehringer Sohn Ingelheim 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7benzomorphane, deren saeureadditionssalze und diese enthaltende arzneimittel
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
JPS5636521A (en) * 1979-08-31 1981-04-09 Shin Etsu Chem Co Ltd Production of alkenyloxy group-containing organopolysiloxane
JP5470557B2 (ja) 2007-07-26 2014-04-16 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
TW200927115A (en) 2007-11-16 2009-07-01 Boehringer Ingelheim Int Aryl-and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8598160B2 (en) 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
RU2531272C2 (ru) 2008-05-01 2014-10-20 Вайтаи Фармасьютиклз, Инк. Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
JP5696037B2 (ja) 2008-05-01 2015-04-08 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
AR071719A1 (es) 2008-05-13 2010-07-07 Boehringer Ingelheim Int Derivados aliciclicos de acido carboxilico de benzomorfanos y estructuras relacionadas, medicamentos que contienen dichos compuestos y su uso.procesos de obtencion
WO2010010157A2 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
NZ590495A (en) 2008-07-25 2012-10-26 Vitae Pharmaceuticals Inc Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
AR078887A1 (es) 2009-11-06 2011-12-07 Boehringer Ingelheim Int Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
WO2011159760A1 (en) 2010-06-16 2011-12-22 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
WO2013025664A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Indenopyridine derivatives
WO2022113437A1 (ja) 2020-11-26 2022-06-02 信越化学工業株式会社 室温硬化性オルガノポリシロキサン組成物及び物品並びに加水分解性オルガノシラン化合物及びその製造方法
JP7800552B2 (ja) 2021-09-03 2026-01-16 信越化学工業株式会社 オルガノポリシロキサン化合物、室温硬化性オルガノポリシロキサン組成物、及び物品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE582575A (https=) * 1958-09-22
US3700734A (en) * 1969-01-23 1972-10-24 Merck & Co Inc 2{40 -hydroxy-2,3,5-trimethyl-6,7-benzomorphan
DE2105743C3 (de) * 1971-02-08 1979-11-29 Boehringer Sohn Ingelheim 2-(Furylmethyl)- a -5,9-dialkyl -6,7benzomorphane, Verfahren zu ihrer Herstellung und deren Verwendung
CS166802B2 (https=) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim
DE2200596A1 (de) * 1972-01-07 1973-07-12 Boehringer Sohn Ingelheim N-(furyl-methyl)-2'-hydroxy-5-phenyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2217420C3 (de) * 1972-04-12 1981-03-12 C.H. Boehringer Sohn, 6507 Ingelheim N-Thienylmethyl-Heterocyclen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2229695A1 (de) * 1972-06-19 1974-01-31 Boehringer Sohn Ingelheim 2-(heteroaryl-methyl)-5,9 beta-dialkyl6,7-benzomorphane, deren saeureadditionssalze sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
DK138992B (da) 1978-11-27
SE425392B (sv) 1982-09-27
CH616421A5 (https=) 1980-03-31
BE832099R (fr) 1976-02-04
ZA754997B (en) 1977-04-27
SU587858A3 (ru) 1978-01-05
PL99819B1 (pl) 1978-08-31
CA1049008A (en) 1979-02-20
ES452765A1 (es) 1977-10-16
FI752211A7 (https=) 1976-02-06
ES452768A1 (es) 1977-10-01
BG25089A3 (bg) 1978-07-12
DD122685A5 (https=) 1976-10-20
CH615677A5 (https=) 1980-02-15
SE7508789L (sv) 1976-02-10
NO143460B (no) 1980-11-10
NO752731L (https=) 1976-02-06
PL99816B1 (pl) 1978-08-31
CH615678A5 (https=) 1980-02-15
GB1513950A (en) 1978-06-14
AU8364675A (en) 1977-02-10
ES452766A1 (es) 1977-10-01
HU177952B (en) 1982-02-28
CH613963A5 (https=) 1979-10-31
NL7509249A (nl) 1976-02-09
FI63229B (fi) 1983-01-31
FR2320096A2 (fr) 1977-03-04
RO72735A (ro) 1982-09-09
PL99838B1 (pl) 1978-08-31
DK352875A (da) 1976-02-06
FR2320096B2 (https=) 1978-09-01
CH616420A5 (https=) 1980-03-31
CH615680A5 (https=) 1980-02-15
IE42216B1 (en) 1980-07-02
SU587859A3 (ru) 1978-01-05
JPS5139673A (en) 1976-04-02
JPS60358B2 (ja) 1985-01-07
RO72736A (ro) 1982-09-09
LU73138A1 (https=) 1977-04-13
IL47860A0 (en) 1975-11-25
FI63229C (fi) 1983-05-10
DK138992C (da) 1979-04-30
ES452764A1 (es) 1977-10-16
CH615679A5 (https=) 1980-02-15
ES452763A1 (es) 1977-10-01
IL47860A (en) 1979-01-31
ATA523775A (de) 1978-06-15
BG25088A3 (bg) 1978-07-12
PH13687A (en) 1980-09-01
RO67390A (ro) 1981-06-30
DE2437610A1 (de) 1976-02-26
AT348140B (de) 1979-01-25
IE42216L (en) 1976-02-05
ES452767A1 (es) 1977-10-01
US3982005A (en) 1976-09-21
BG25090A3 (bg) 1978-07-12
CS189717B2 (en) 1979-04-30
NO143460C (no) 1981-02-18

Similar Documents

Publication Publication Date Title
SU591147A3 (ru) Способ получени 5,9- дизамещенных 2-тетрагидрофурфурил-6,7-бензоморфанов или их солей
US5037844A (en) Substituted 1H-indazole-3-carboxamides
FI82689C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefull 2-etoxi-4-/n-(1-(2-piperidino-fenyl)-3-metyl -1-butyl)-aminokarbonylmetyl/-benzoesyras b- och c-form.
US4155909A (en) 2-Alkyl nicotinoids and processes for their production
US4080337A (en) Multioxymacrocycle compounds containing pyridyl rings as part of the macrocycle
US4076820A (en) Benzoquinolizines and hypotensive compositions containing them
KR870001159B1 (ko) 피라졸-환 알킬화된 피라졸로 퀴놀린의 제조방법
SU1042617A3 (ru) Способ получени производных нортропанола или их солей
CA1183836A (en) Dihydrobenzofuranyl derivatives of ala-pro
EP0206090A2 (en) Peptide renin inhibitors
US3751416A (en) 3-(2-(4-phenyl-1-piperazinyl)-ethyl)indolines
Brine et al. An improved resolution of (±)‐cis‐N‐normetazocine
CA2137611A1 (en) Epi-epibatidine derivatives
KR880001320B1 (ko) 2-시클릭아미노-2-(1, 2-벤지속사졸-3-일)아세트산 에스테르 유도체들의 제조방법
SU439982A1 (ru) Способ получени производных эрголена или эрголина
Portoghese et al. Synthesis, x-ray crystallographic determination, and opioid activity of erythro-5-methylmethadone enantiomers. Evidence which suggests that. mu. and. delta. opioid receptors possess different stereochemical requirements
US5756748A (en) Process for the preparation of sameridine
US4160828A (en) Analgesic phosphinyl compounds and compositions
JPS595595B2 (ja) １５−ヒドロキシイミノ−ｅ−ホモエブルナン誘導体の製造方法
JPH01131159A (ja) アクリジニルアミノメタンスルホンアニリド誘導体の製造に有用な中間体の製造法
CN113816994B (zh) (1,1-二氰基-4-氧)-己基-3-氧化吲哚亚膦酸二乙酯及其衍生物的合成方法
US4647666A (en) Heterocyclic synthesis via thallation and subsequent palladium-promoted olefination
SU1038341A1 (ru) Способ получени @ -арилиндолотриметинцианинов
US4425349A (en) Sulfur-containing isoquinoline derivatives in pharmaceutical compositions and methods of use
US4358452A (en) N-[1,2,3,4,6,7,12,12 α-octahydro-2H-indolo(2,3α)-quinolizinyl-2β-yl]alkane and benzyl sulfonamides and anti-hypertensive use thereof